The major Japanese generics firm Nichi-Iko has signalled its intention to move into the biosimilars sector in the US through the establishment of a new subsidiary in this market.
Wilmington, Delaware-based NIXS Corp has been set up as a wholly owned operation to support the development and commercialization of...